New Delhi: Close on the heels of New Delhi’s warning to the UK of reciprocal measures if it did not approve Covishield, the latter has included the AstraZeneca vaccine in its list of approved Covid-19 vaccines.
However, there is no clarity on recognition to the vaccine certification in India, which still does not appear in the list of countries whose vaccination is approved.
This means that those who have received Covishield in India will still have to be quarantined in the UK
The updated guidelines for travellers to the UK say that they can enter the UK from October 4 if they are fully vaccinated under an approved vaccination programme in the UK, Europe, US or UK vaccine programme overseas.
The travellers should have completed a full course of Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccine from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan.
AstraZeneca’s Covidshield is manufactured in India by the Serum Institute of India.
Earlier, UK’s refusal to include Covishield on the list of approved vaccines had been called ‘discriminatory’ by India.
Earlier, foreign secretary Harsh Vardhan Shringla had said, “Have raised the discriminatory nature of UK vaccine recognition for AstraZeneca but not Covishield. Discussions on, but if they do not satisfy us, we would be well within our rights to take reciprocal action.”
To read the latest news in Gujarati click here